Super Achiever Club
Reviewed
Verified by SAC team
+20
XP on completion
Bulk Alpha-GPC
BulkSupplements.com

BulkSupplements Alpha GPC Capsules 300mg Review

5.5/10SAC Product Score™

BulkSupplements delivers a large, no-frills supply of Alpha-GPC at 600mg per two-cap serving. For someone who wants a lot of Alpha-GPC cheaply, it is efficient. But it is the same brain-oriented form as the NOW pick with lighter branding, and on a liver-health ranking it takes the bottom slot: off-target form, low elemental choline, and testing limited to an in-house lab.

Check on Amazon

Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.

Read the complete Choline guide →
▸ THE SCORE

How we built the SAC Product Score™ — 5.5/10

Form & bioavailability (liver/methylation fit)30%4.5/10

Alpha-GPC is brain-targeted and least relevant to hepatic fat export. As a bulk single-ingredient it adds no liver-specific benefit, so it scores lowest on fit.

Dose vs RDA/clinical range20%6/10

600mg Alpha-GPC per 2-cap serving yields ~240mg elemental choline, the most among the Alpha-GPC options but still a cognition-style dose, not a liver protocol.

Third-party testing & purity20%5/10

Gluten-free and GMP with in-house lab testing, but in-house rather than independent third-party verification is a step below the top brands.

Tolerability & safety15%7/10

Generally well tolerated; the same observational cardiovascular caveat as other Alpha-GPC applies at higher chronic doses.

Value15%6/10

Around $25 for 180 caps (90 servings) is decent bulk value for Alpha-GPC, though costly per gram of choline for a liver purpose.

▸ SPECS

The product at a glance

Form
Capsule (Alpha-GPC)
Dose
300mg per cap; 600mg (~240mg choline) per 2-cap serving
Count
180 capsules (90 servings)
Standardization
~40% choline by weight, single-ingredient
Testing
Gluten-free, in-house lab tested, GMP
Cost per dose
~$0.28 per 2-cap serving (approx, not live-checked)
▸ TRUTH CHECK

Marketing claims vs. reality

Verified

“High-dose bulk Alpha-GPC at good value”

180 caps (90 two-cap servings of 600mg) for ~$25 is genuine bulk value for the Alpha-GPC form.

Not verified

“Appropriate for liver-health goals”

Alpha-GPC has no NAFLD evidence and is the most brain-targeted form; it is the least fitting choice for a liver list (PMID 22337211).

▸ THE DEEP DIVE

What our test actually found

01Bulk cognition, not liver therapy

The product is optimized for buyers who want a lot of Alpha-GPC for focus. Its evidence base is cognitive (PMID 12637119), leaving it bottom-ranked for a liver goal.

02In-house testing caveat

BulkSupplements uses its own lab rather than fully independent third-party certification, which is acceptable but ranks below Thorne and the clinician-line brands on verification.

▸ THE TRADE-OFFS

Pros & cons, no sugar-coating

Pros
  • Best bulk value among Alpha-GPC options
  • Highest elemental choline per serving of the Alpha-GPC picks
  • Clean single-ingredient, gluten-free formula
  • Large 90-serving supply
Cons
  • Least appropriate form for the liver goal
  • In-house rather than independent third-party testing
  • Same cardiovascular observational caveat at higher chronic doses
▸ THE BOTTOM LINE

Bottom of a liver list, fine for the brain

If you want a big, cheap supply of Alpha-GPC for cognition, this works. For the liver/methylation purpose of this ranking it is the weakest fit; choose Pure Encapsulations bitartrate or Thorne phosphatidylcholine instead.

Check BulkSupplements.com on Amazon
▸ ALTERNATIVES

If this doesn’t fit — try these

NOW Alpha GPC 300mg

5.8/10

Same form from a more established, GMP-trusted brand.

See it on the list →

Pure Encapsulations Choline (Bitartrate) 275mg

8.4/10

The right form and the best pick for the liver/methylation goal.

See it on the list →
▸ RESEARCH

Sources & further reading

  1. De Jesus Moreno Moreno M. Clin Ther. 2003;25(1):178-193.De Jesus Moreno Moreno M · 2003 · Clinical Therapeutics · PMID 12637119

    Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial

    Alpha-GPC improved cognition versus placebo, confirming its brain-focused, not liver-focused, evidence base.

  2. Sherriff JL, et al. Adv Nutr. 2016;7(1):5-13.Sherriff JL, O'Sullivan TA, Properzi C, et al. · 2016 · Advances in Nutrition · PMID 26773011

    Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes

    Choline's NAFLD role is plausible but unproven outside deficiency, and no form including Alpha-GPC is a demonstrated treatment.